Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes
- PMID: 28357066
- PMCID: PMC5351308
- DOI: 10.3892/br.2016.833
Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes
Abstract
Coding synonymous single nucleotide polymorphisms (SNPs) have attracted little attention until recently. However, such SNPs located in epigenetic, CpG sites modifying exonic splicing enhancers (ESEs) can be informative with regards to the recently verified association of intragenic methylation and splicing. The present study describes the association of type 2 diabetes (T2D) with the exonic, synonymous, epigenetic SNPs, rs3749166 in calpain 10 (CAPN10) glucose transporter (GLUT4) translocator and rs5404 in solute carrier family 2, member 2 (SLC2A2), also termed GLUT2, which, according to prior bioinformatic analysis, strongly modify the splicing potential of glucose transport-associated genes. Previous association studies reveal that only rs5404 exhibits a strong negative T2D association, while data on the CAPN10 polymorphism are contradictory. In the present study DNA from blood samples of 99 Greek non-diabetic control subjects and 71 T2D patients was analyzed. In addition, relevant publicly available cases (40) resulting from examination of 110 Personal Genome Project data files were analyzed. The frequency of the rs3749166 A allele, was similar in the patients and non-diabetic control subjects. However, AG heterozygotes were more frequent among patients (73.24% for Greek patients and 54.55% for corresponding non-diabetic control subjects; P=0.0262; total cases, 52.99 and 75.00%, respectively; P=0.0039). The rs5404 T allele was only observed in CT heterozygotes (Greek non-diabetic control subjects, 39.39% and Greek patients, 22.54%; P=0.0205; total cases, 34.69 and 21.28%, respectively; P=0.0258). Notably, only one genotype, heterozygous AG/CC, was T2D-associated (Greek non-diabetic control subjects, 29.29% and Greek patients, 56.33%; P=0.004; total cases, 32.84 and 56.58%, respectively; P=0.0008). Furthermore, AG/CC was strongly associated with very high (≥8.5%) glycosylated plasma hemoglobin levels among patients (P=0.0002 for all cases). These results reveal the complex heterozygotic SNP association with T2D, and indicate possible synergies of these epigenetic, splicing-regulatory, synonymous SNPs, which modify the splicing potential of two alternative glucose transport-associated genes.
Keywords: CAPN10; HbA1c; SLC2A2; bioinformatics analysis; family history; heterozygosity; synonymous CpG polymorphisms.
Figures


Similar articles
-
Risk-associated coding synonymous SNPs in type 2 diabetes and neurodegenerative diseases: genetic silence and the underrated association with splicing regulation and epigenetics.Mutat Res. 2014 Dec;770:85-93. doi: 10.1016/j.mrfmmm.2014.09.005. Epub 2014 Sep 27. Mutat Res. 2014. PMID: 25771874
-
Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes.Neuromolecular Med. 2010 Sep;12(3):260-9. doi: 10.1007/s12017-009-8111-0. Epub 2010 Jan 14. Neuromolecular Med. 2010. PMID: 20077034
-
Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.Physiol Genomics. 2007 Oct 22;31(2):264-72. doi: 10.1152/physiolgenomics.00036.2007. Epub 2007 Jul 17. Physiol Genomics. 2007. PMID: 17636114 Clinical Trial.
-
Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.Am J Hum Genet. 2004 Feb;74(2):208-22. doi: 10.1086/381400. Epub 2004 Jan 13. Am J Hum Genet. 2004. PMID: 14730479 Free PMC article.
-
CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes.Biochem Biophys Res Commun. 2007 Jul 6;358(3):831-6. doi: 10.1016/j.bbrc.2007.05.001. Epub 2007 May 7. Biochem Biophys Res Commun. 2007. PMID: 17511963
Cited by
-
Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms.Int J Mol Sci. 2022 Dec 23;24(1):271. doi: 10.3390/ijms24010271. Int J Mol Sci. 2022. PMID: 36613718 Free PMC article.
-
RNA Splicing: A New Paradigm in Host-Pathogen Interactions.J Mol Biol. 2019 Apr 5;431(8):1565-1575. doi: 10.1016/j.jmb.2019.03.001. Epub 2019 Mar 8. J Mol Biol. 2019. PMID: 30857970 Free PMC article. Review.
-
Alternative splicing isoforms in health and disease.Pflugers Arch. 2018 Jul;470(7):995-1016. doi: 10.1007/s00424-018-2136-x. Epub 2018 Mar 13. Pflugers Arch. 2018. PMID: 29536164 Review.
-
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.Clin Epigenetics. 2020 Jul 11;12(1):104. doi: 10.1186/s13148-020-00896-4. Clin Epigenetics. 2020. PMID: 32653024 Free PMC article. Review.
-
From Gene to Protein-How Bacterial Virulence Factors Manipulate Host Gene Expression During Infection.Int J Mol Sci. 2020 May 25;21(10):3730. doi: 10.3390/ijms21103730. Int J Mol Sci. 2020. PMID: 32466312 Free PMC article. Review.
References
-
- Romero PR, Zaidi S, Fang YY, Uversky VN, Radivojac P, Oldfield CJ, Cortese MS, Sickmeier M, LeGall T, Obradovic Z, et al. Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc Natl Acad Sci USA. 2006;103:8390–8395. doi: 10.1073/pnas.0507916103. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources